Package 83301-0025-2

{"route": ["ORAL"], "spl_id": "4990307c-8f79-4a7b-e063-6294a90a7b94", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["75b1e027-4c5d-46e5-98ee-033e67bd411c"], "manufacturer_name": ["Mullan Pharmaceutical Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (83301-0025-1)", "package_ndc": "83301-0025-1", "marketing_start_date": "20240617"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (83301-0025-2)", "package_ndc": "83301-0025-2", "marketing_start_date": "20240617"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (83301-0025-3)", "package_ndc": "83301-0025-3", "marketing_start_date": "20240617"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (83301-0025-4)", "package_ndc": "83301-0025-4", "marketing_start_date": "20240617"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "83301-0025_4990307c-8f79-4a7b-e063-6294a90a7b94", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "83301-0025", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Mullan Pharmaceutical Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride (XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA208652", "marketing_category": "ANDA", "marketing_start_date": "20240617", "listing_expiration_date": "20271231"}